This is a working overview of WADA prohibited list, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-10-15 and is reviewed periodically as new material appears.
Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized form; may appear as cake |
| Solubility class | Water-soluble | Often reconstituted in aqueous buffer |
| Typical storage temperature | −20 °C or below | Protect from light and moisture |
| Typical analytical method | RP-HPLC and mass spectrometry | Used for purity and identity |
| Common synonyms | AOD-9604; AOD9604; hGH fragment 176-191 | Research name and fragment description |
Stability of AOD-9604 depends on storage conditions. Lyophilized powder is generally more stable than reconstituted solution. Recommended storage is typically at -20°C or lower, protected from light and moisture. Repeated freeze-thaw cycles can cause aggregation or degradation. In solution, the peptide may be susceptible to hydrolysis or oxidation, so aliquoting and cold storage are common practices. Researchers often add stabilizers such as mannitol or trehalose during lyophilization to improve shelf life.
Quality control for AOD-9604 involves verifying identity, purity, and concentration. Suppliers may provide a certificate of analysis listing HPLC purity and mass spectrometry data. Independent verification is advised because peptide products can vary in quality. Researchers should check for counterions, residual solvents, and microbial contamination. Proper documentation supports reproducibility and safety in laboratory studies. When sourcing, institutions often require third-party testing and detailed chain-of-custody records. These steps help ensure that experimental results are attributable to the peptide rather than impurities.
Proposed mechanism focuses on lipolysis, the breakdown of stored triglycerides into free fatty acids and glycerol. AOD-9604 is thought to act on adipose tissue without stimulating appetite or affecting blood sugar in the same way as growth hormone. Laboratory studies report increased fat oxidation in some models. The precise receptor interactions and signaling pathways remain incompletely characterized. Researchers have proposed that the peptide may influence fat mobilization through pathways distinct from the full hormone.
Research has examined whether the peptide affects fat mass independently of growth hormone's other actions. Early animal studies suggested reductions in body fat, but species differences and small sample sizes limit interpretation. Human studies have generally been short and have not consistently shown large effects. Some trials measured body composition, lipid profiles, and safety parameters, but the overall picture is one of suggestive yet inconclusive metabolic activity. Findings vary across study populations and protocols.
== History == The arrangement of three quadrupoles was first developed by J.D. Morrison of La Trobe University, Australia for the purpose of studying the photodissociation of gas-phase ions. After coming into contact with Prof. Christie G. Enke and his then graduate student Richard Yost, Morrison's linear arrangement of the three quadrupoles probed the construction of the first triple-quadrupole mass spectrometer. In the years following, the first commercial triple-quadrupole mass spectrometer was developed at Michigan State University by Enke and Yost in the late 1970s. It was later found that the triple-quadrupole mass spectrometer could be utilized to study organic ions and molecules, thus expanding its capabilities as a tandem MS/MS technique.
==== Tim Hortons ==== The parent company of Cold Stone Creamery, Kahala Brands, announced in February 2009 that it had reached an agreement with Canadian coffee shop chain Tim Hortons to open 100 co-branded stores in the United States after successfully testing two locations in Rhode Island. The strategic alliance was intended to pave the way for Tim Hortons to operate in more US locations while allowing Cold Stone Creamery to expand into Canada. The most notable co-branded store opened in August 2009 when Tim Hortons moved into three Cold Stone Creamery locations in New York City, including its flagship Times Square location. In June 2009, Cold Stone Creamery started testing the Canadian market by opening seven co-branded locations with Tim Hortons in Toronto, Oakville, Mississauga, Hamilton, Pickering, Sudbury, and Halifax, Nova Scotia. They had locations in every Canadian province except for Newfoundland and Labrador. The Tim Hortons venture followed on the footsteps of a similar co-branding efforts in 2007 and 2008, but ended in 2014.
=== Books === Separation Processes (1971); 2nd edition (1980) Freeze Drying of Foods (1971) The University of California: Creating, Nurturing, and Maintaining Academic Quality in a Public University Setting (2018)
Australia: Electronic Travel Authority (ETA) eVisitor programme East African Community: From February 2014, Kenya, Rwanda and Uganda issue an East African Tourist Visa. Hong Kong: Mainland Travel Permit for Taiwan Residents India: India permits nationals of most jurisdictions to clear border controls using an e-visa. Kenya: From 1 January 2021, Kenya solely issues e-visas, and physical visas are no longer available. New Zealand: Electronic Travel Authority (NZeTA) North America: Canadian ETA, US Electronic System for Travel Authorisation Pakistan: Pakistani ETA. South Korea: eligible visa-free visitors must obtain Korea Electronic Travel Authorization (K-ETA). Sri Lanka: Sri Lankan ETA Qatar: ETA needed for up to 30 days. United Kingdom: Electronic Visa Waiver, or EVW The Nationality and Borders Bill, before the parliament in Spring 2022, includes a proposal to introduce the Electronic Travel Authorisation system for all non-UK and Irish citizens.
phosphodiester bond A pair of ester bonds linking a phosphate molecule with the two pentose rings of consecutive nucleosides on the same strand of a nucleic acid. Each phosphate forms a covalent bond with the 3' carbon of one pentose and the 5' carbon of the adjacent pentose; the repeated series of such bonds that holds together the long chain of nucleotides comprising DNA and RNA molecules is known as the phosphate or phosphodiester backbone.
Sources: en.wikipedia.org
=== Agriculture === Within a temperature regulated bath, seeds are rested between moisturized blotting paper as a germination device. This method is typically used in seed germinators, which create balanced conditions of humidity and temperature.
One person was killed in a Russian attack in Kherson Oblast. Russian-installed officials in Luhansk Oblast claimed that a gas pipeline was damaged by a missile attack in Pervomaisk. The HUR claimed that it had destroyed two Russian KS-701 Tunets patrol boats and damaged two other vessels in Vuzka Bay in Chornomorske, Crimea, using naval drones. SBU drones destroyed a Russian Nebo-SVU radar system in Armiansk, Crimea. President Biden gave Ukraine permission to use weapons provided by the U.S. to attack Russian units in Russian soil in the vicinity of Kharkiv. Germany announced another military aid package for Ukraine worth €500 million ($540 million) that would include artillery, air defence and drones.
== Academic and scientific activities == A graduate of Ursinus College, Pennsylvania in 1986, Conway subsequently studied at the Burke Chemical Laboratories of Dartmouth College, New Hampshire, where he obtained his Ph.D. in 1991. His thesis concerned the attempted generation of indolyne (an aromatic compound related to indole). After college, Conway took a postdoctoral appointment in Chicago, later working as a contractor for the Food and Drug Administration, a researcher for Bionetics, a medicinal chemist for Avid Therapeutics (March 1995 – August 1997) and researcher for Message Pharmaceuticals (August 1997 – April 1999). He spent two years in organ distribution at the National Disease Research Interchange, and was subsequently employed by crop protection company Cerexagri as a regulatory chemist from May 2001 to June 2007, when he became a principal chemist for West Pharmaceutical Services. As of July 2013, he was working for a group near Raleigh, North Carolina. Conway has authored eleven professional publications and two patents. One patent covers compounds intended to treat hepatitis B in synergy with lamivudine; another relates to recyclable packaging material. His work has been published in Heterocycles, Synthetic Communications, Organic Preparations and Procedures International, Water Research, Rapid Communications in Mass Spectrometry, Antimicrobial Agents and Chemotherapy, Bioorganic & Medicinal Chemistry Letters and Current Organic Chemistry.
, the spreading slows down thus useful to set a prediction on the short-term trends. Also, it can be used to directly calculate the threshold population of vaccination/immunization for the herd immunity stage by setting
Sources: en.wikipedia.org
demonstrated DE sorting and isolation on-chip followed by FACS that allows for high sorting throughput of encapsulated mammalian cells, from which genetic material can later be extracted. While fluorogenic labeling is a powerful tool for tracking and sorting, it is not always compatible with droplet-based microfluidic systems and experimental design. New label-free and non-fluorescence-based detection techniques have recently been reported. In 2016, Gielen et al. published an absorbance-activated droplet sorting (AADS) microfluidic device and demonstrated its functionality by directing the evolution of a phenylalanine dehydrogenase. In 2016, Sun et al. demonstrated the use of SE droplets and high-throughput MS to screen enzyme activators and inhibitors by screening a transaminase library. In 2019, Pan et al. showed sorting of droplets by interfacial tensions, which are affected by droplet content. In 2020, Haidas et al. presented a microfluidic approach that uses both matrix-assisted laser desorption ionization mass spectrometry (MALDI-MS) and fluorescence microscopy, which the authors used to measure the concentration and activity of phytase, respectively, in yeast cells. In 2020, Holland-Moritz et al. published their mass activated droplet sorting (MADS) method, which integrates MS analysis with fluorescence-activated droplet sorting (FADS). Using this method, droplets are split and analyzed separately by both MS and FADS. The power of this method was demonstrated by screening the activity of a transaminase library expressed in vitro.
Beginning with the Gin Craze, excessive drinking and drunkenness developed into a major problem for public health. In 1874, Francis E. Anstie's experiments showed that the amounts of alcohol eliminated unchanged in breath, urine, sweat, and feces were negligible compared to the amount ingested, suggesting it was oxidized within the body. In 1902, Atwater and Benedict estimated that alcohol yielded 7.1 kcal of energy per gram consumed and 98% was metabolized. In 1922, Widmark published his method for analyzing the alcohol content of fingertip samples of blood. Through the 1930s, Widmark conducted numerous studies and formulated the basic principles of ethanol pharmacokinetics for forensic purposes, including the eponymous Widmark equation. In 1980, Watson et al. proposed updated equations based on total body water instead of body weight. The TBW equations have been found to be significantly more accurate due to rising levels of obesity worldwide.
With scores greater or equal to 1.0 or 100%, the concept of "limiting amino acid" technically still applies as the amino acid with the lowest ratio compared to the amounts in the reference protein. It is hardly relevant, however, so such columns are parenthesized. PD is determined per PDCAAS ("true fecal") unless otherwise stated. AAS explicitly does not take into account digestibility. It compares the amino acid profile to a reference profile, which is the PDCAAS profile unless otherwise stated. Limiting AA may be determined by either PDCAAS (or a similar profile-only method) or the DIAAS (which gives the limiting absorbed AA). If unstated it is more likely to be PDCAAS. PDCAAS values are officially capped, but the limit can be removed by manually calculating PD × AAS. Examples of 5 uncapped values are seen in Schaafsma (2000).
Sources: en.wikipedia.org
Lyophilized powder is commonly stored at −20 °C or below, protected from light and moisture. Reconstituted solutions are typically kept refrigerated and used within a limited period.
Reversed-phase HPLC and mass spectrometry are standard checks. They confirm peptide purity and molecular mass, but they do not by themselves demonstrate biological activity.
Synthesis, purification, and handling conditions can differ, leading to variations in purity and salt content. Certificates of analysis help, but independent testing is often needed for verification.
Yes, the World Anti-Doping Agency classifies AOD-9604 as a prohibited peptide hormone and related substance. Its use by athletes is banned under the relevant anti-doping code.